Key Takeaways
- Revenue up ~48% YoY, exports surge: Exports jumped to 30% of revenue from 18% QoQ, driven by a rebound in US oil and gas and rising merchant exports, while the distribution business held steady on top line with improved margins.
- Manufacturing margins improved despite input cost pressure: Strategic raw material procurement and logistics management lifted acrylamide liquid margins, and a new ceramic binder boosted PAM liquid sales over 50% above the prior quarter's monthly average, even as acrylonitrile prices rose.
- Subsidiary closure simplifies structure and frees cash: B.R. Chemicals Co. Ltd. wound up on 30th January after fulfilling its primary objective, improving consolidated cash flow and profitability with no pending costs.
- Secrecy around Japanese JV persists, frustrating disclosure: Management declined to name the partner or chemical, citing confidentiality agreements, and said the right time to disclose is when the environment clearance application is approved.
- What to watch next quarter: Whether logistics easing converts to volume growth, the pace of acrylamide solid export pick-up as China prices rise, and any disclosure milestone on the Japanese brownfield project.
Revenue Drivers & Product Performance
- Distribution business steady, exports double: Top line remained stable while operational margins improved through better planning; exports more than doubled as merchant exports increased, with the US oil and gas sector providing a significant boost.
- New binder transforms PAM liquid trajectory: The robust ceramic binder introduced late last quarter was well accepted and already increased sales by more than 50% from the prior quarter's average monthly sales; expected to contribute more significantly next quarter.
- Acrylamide solid benefits from China price rise: Rising ex-China prices for AAM solid Eclipse powder helped the company cater to Indian customers with a fair pricing policy; exports expected to pick up during the current quarter with substantial growth forecasted.
- Resorcinol sales hit by local price war: Sales fell due to price cutting by the sole local producer, but volumes are expected to increase in the current quarter as demand returns from key customers.
- NMA domestic demand dips slightly, export push underway: One key customer rolled over orders, causing a slight domestic decline; the company is adding new export customers, and management sees the main growth in NMA coming from export markets, which are much larger than India.
- Acrylonitrile supply secure despite price rise: Prices started the quarter at ~$1,200 and rose another $100 in the current month; management sees no supply challenge because global acrylonitrile overcapacity persists, with China adding more capacity than demand growth.
Ambarish Daga: "as a general, policy or a general framework, we would be entering into manufacturing arrangement only when there are better margins compared to the distribution business. Otherwise, it would not make any sense for manufacturing."
Margin Structure & Profitability Path
- EBITDA margin improved to ~10% from ~8%: The improvement was described as a healthy sign of growth and strategic planning, achieved despite rising raw material prices and logistics headwinds.
- Net profit margins are low because distribution dominates: At 75% of revenue, the lower-margin distribution business drags down consolidated net margins to 5-6%; manufacturing margins are much higher even at low capacity utilization, and as scale grows, manufacturing margins keep increasing.
- Logistics logjams held back performance materially: Extremely high freight rates constrained results; management stated that had logistics not been an issue, the company would have done much better than it already has, and expects easing in upcoming quarters to help volumes pick up further.
- Future margin expansion tied to manufacturing mix shift: As new products come online and manufacturing contribution increases, net profit margins will change substantially and reach comparable levels with other specialty chemical companies.
Ambarish Daga: "as the scale of operation will grow, as the size of the company grows, as the segment wise distribution pattern changes between the distribution business and the manufacturing business, you will see much healthier net profit margins overall for the company."
Strategic Projects & Capex
- Polyacrylamide solids technology nearing completion: Technology development expected to be completed by end of this financial year, with commercialization targeted towards the end of the upcoming financial year; capex projection is ₹60-100 crores.
- Japanese brownfield specialty chemical project advancing: The final environment clearance application is being submitted within this week; management remains bound by secrecy agreements and declined to name the partner or chemical, stating disclosure will come when the EC application is approved.
- Dahej land bank being secured for future projects: Land near Dahej has been finalized and the process of securing it is underway; the land is specifically to create a land bank and is not earmarked for any finalized upcoming project.
- New R&D center to be completed by end of this quarter: A Vice President for Innovation has been appointed to strengthen the entire R&D capability.
- Toll manufacturing discussions progressing slowly: The two agreements with US and European companies are still being worked on but have not progressed as fast as expected; no environment clearance has been filed yet.
- Capex plans unchanged, funding options open: Total projection is ₹20-40 crores for the new land and upcoming specialty chemicals project, plus ₹60-100 crores for PAM solid; the company has its own resources and retained earnings but is open to all options including debt or additional equity, with no decision made yet.
Ambarish Daga: "in all such collaborations, basically there are secrecy agreements which bars us from mentioning too much details."
External Environment & Opportunities
- US tariffs seen as a big opportunity, impact unclear: The 10% duty on Chinese goods is viewed as helpful for both manufactured and distribution business, but management said it is difficult to gauge actual impact currently and more clarity is expected in the next couple of months.
- Europe plus one policy helping market presence: The company is adding new geographies and new customers as the policy creates tailwinds for Indian exporters.
- BIS regulations not a major threat, may open manufacturing doors: Most of the distribution business is not expected to see any major impact; the regulations might create additional manufacturing possibilities in the future.
- Oil and gas demand remains robust: The company is currently concentrating on the ~10,000 ton market in India; if market dynamics change, management is open to looking at the larger oil and gas segment, describing itself as proactive in business strategies.
Ambarish Daga: "the duty will definitely help and we see that as a big opportunity for not just our manufactured business, but also for our distribution business... But we'll have to see how it finally plays out. Currently it's just been announced so it is difficult to gauge the actual impact."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Polyacrylamide solids technology completion | Technology development finished | End of current financial year |
| Polyacrylamide solids commercialization | Commercial production begins | Towards end of upcoming financial year |
| New R&D center completion | Facility operational | End of this quarter |
| Brownfield specialty chemical EC application | Final application submitted | Within this week (from call date) |
| Volume and revenue growth | Substantial growth in both, focus on exports | Current financial year |
| Logistics easing to support volumes | Freight rates declining, issues easing out | Next upcoming quarters |
| Japanese JV disclosure | More information provided publicly | When EC application is approved |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Revenue from operations | ~48% YoY growth, minor dip QoQ |
| EBITDA margin | ~10%, improved from ~8% in the corresponding quarter of the previous year |
| PAT margin | Healthy growth YoY |
| Return on capital employed | 19% |
| Exports share of revenue | 30%, up from 18% in Q2 FY25 |
| Distribution share of revenue | ~2/3 |
| Distribution business exports | More than double YoY |
| Top 5 distribution products share of distribution top line | 93% |
| Top 5 distribution products share of distribution profits | 85% |
| Acrylonitrile price | ~$1,200 at quarter start, rose gradually; up another $100 in the current month |
| New binder product sales growth | >50% over average monthly sales of Q2 FY25 |
| Unallocated revenue | ₹86 lakhs, with an operating loss of ~₹1 crore |
| Long-term debt | Nil, company remains long-term debt free |
| Debt-equity ratio | Negligible |